Prognostic Value of Kallikrein-Related Peptidase 12 (KLK12) mRNA Expression in Triple-Negative Breast Cancer Patients

Molecular Medicine - United States
doi 10.1186/s10020-020-0145-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society for Mining, Metallurgy and Exploration Inc.

Related search

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Prognostic Influence of Cyclooxygenase-2 Protein and mRNA Expression in Node-Negative Breast Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature With Predictive and Prognostic Value

Cancer Research
Cancer ResearchOncology
2016English

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

The Prognostic Value of BRCA1 Promoter Methylation in Early Stage Triple Negative Breast Cancer

journal of Cancer Therapeutics and Research
2014English

New Insights Into the Prognostic Value of Ki-67 Labeling Index in Patients With Triple-Negative Breast Cancer

Oncotarget
Oncology
2016English

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy